Kappa Bioscience

Kappa Bioscience AS, established in 2006 and headquartered in Oslo, Norway, specializes in the development and production of vitamin K2 as menaquinone-7. The company pioneers the synthesis of MK-7, offering it under the brand name K2VITAL to food supplement and fortified food manufacturers worldwide through its global sales division Kappa Ingredients GmbH and a network of distributors. Kappa Bioscience's product portfolio includes microencapsulated DELTA for stability in mineral formulations, along with other vitamin K2 variants like MK-7 for food supplements and fortified foods. The company's innovations ensure high ingredient purity, scalability, and secure supply chains, enabling broader market access for its clients.